Winner Medical Co., Ltd. (300888.SZ)
CNY 48.16
(4.92%)
CNY 48.16
(4.92%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.49 Billion CNY | -12.09% |
| 2022 | 2.83 Billion CNY | 374.53% |
| 2021 | 597.99 Million CNY | 298.47% |
| 2020 | 150.07 Million CNY | -42.98% |
| 2019 | 263.18 Million CNY | -13.48% |
| 2018 | 304.2 Million CNY | -23.63% |
| 2017 | 398.31 Million CNY | 548.16% |
| 2016 | 61.45 Million CNY | 148.55% |
| 2015 | 24.72 Million CNY | -82.46% |
| 2014 | 140.98 Million CNY | -38.22% |
| 2013 | 228.21 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.22 Billion CNY | -0.29% |
| 2024 Q3 | 2.74 Billion CNY | 3.06% |
| 2024 Q1 | 2.22 Billion CNY | -10.63% |
| 2023 Q3 | 2.06 Billion CNY | -15.39% |
| 2023 FY | 2.49 Billion CNY | -12.09% |
| 2023 Q4 | 2.49 Billion CNY | 20.89% |
| 2023 Q1 | 3.11 Billion CNY | 9.73% |
| 2023 Q2 | 2.43 Billion CNY | -21.68% |
| 2022 Q3 | 2.46 Billion CNY | 44.19% |
| 2022 Q1 | 647.25 Million CNY | 8.24% |
| 2022 FY | 2.83 Billion CNY | 374.53% |
| 2022 Q4 | 2.83 Billion CNY | 15.3% |
| 2022 Q2 | 1.7 Billion CNY | 163.7% |
| 2021 Q4 | 597.99 Million CNY | -0.48% |
| 2021 Q2 | 616.98 Million CNY | 6.03% |
| 2021 Q1 | 581.87 Million CNY | 287.73% |
| 2021 FY | 597.99 Million CNY | 298.47% |
| 2021 Q3 | 600.87 Million CNY | -2.61% |
| 2020 Q3 | 155 Million CNY | 0.0% |
| 2020 FY | 150.07 Million CNY | -42.98% |
| 2020 Q2 | 155 Million CNY | 0.0% |
| 2020 Q4 | 150.07 Million CNY | -3.18% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q1 | 384.77 Million CNY | 0.0% |
| 2019 FY | 263.18 Million CNY | -13.48% |
| 2019 Q4 | 263.18 Million CNY | 0.0% |
| 2019 Q2 | 389.76 Million CNY | 1.3% |
| 2018 FY | 304.2 Million CNY | -23.63% |
| 2017 FY | 398.31 Million CNY | 548.16% |
| 2016 FY | 61.45 Million CNY | 148.55% |
| 2015 FY | 24.72 Million CNY | -82.46% |
| 2014 FY | 140.98 Million CNY | -38.22% |
| 2013 FY | 228.21 Million CNY | 0.0% |